PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Analysts Set New Price Targets
Separately, Morgan Stanley reduced their target price on PetMed Express from $20.00 to $19.00 and set an "underweight" rating for the company in a research report on Tuesday, July 26th.
PetMed Express Stock Performance
Shares of NASDAQ:PETS traded down $0.31 during midday trading on Wednesday, reaching $23.21. 11,107 shares of the company traded hands, compared to its average volume of 467,043. The firm has a market cap of $487.18 million, a PE ratio of 24.50 and a beta of 0.59. The stock's 50-day simple moving average is $21.46 and its 200-day simple moving average is $23.46. PetMed Express has a 12 month low of $19.08 and a 12 month high of $32.67.
PetMed Express (NASDAQ:PETS - Get Rating) last issued its quarterly earnings data on Monday, July 25th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.25 by ($0.11). PetMed Express had a net margin of 7.36% and a return on equity of 13.77%. During the same period in the prior year, the firm earned $0.26 EPS. On average, equities research analysts expect that PetMed Express will post 0.91 EPS for the current year.
PetMed Express Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, August 19th. Investors of record on Friday, August 12th will be issued a $0.30 dividend. The ex-dividend date is Thursday, August 11th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.17%. PetMed Express's dividend payout ratio is 125.00%.